We are live on
!
Find out more
iBio
IBIO
IBIO
16 hedge funds and large institutions have $329K invested in iBio in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
67% more capital invested
Capital invested by funds: $197K → $329K (+$132K)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
33% more funds holding
Funds holding: 12 → 16 (+4)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
Holders
16
Holders Change
+4
Holders Change %
+33.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$194K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$32K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$24.4K |
| 4 |
VF
Virtu Financial
New York
|
+$15.7K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$9.36K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$22K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$21K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.3K |
| 4 |
Morgan Stanley
New York
|
-$136 |
